The Mildly Decreased Preoperative Bilirubin Level is a Risk Factor for Periprosthetic Joint Infection After Total Hip and Knee Arthroplasty

Overview

Journal Arthroplasty

Publisher Biomed Central

Date 2022 Mar 3

PMID 35236483

Authors

Jun Fu

Xiyue Chen

Ming Ni

Xiang Li

Libo Hao

Guoqiang Zhang

Jiying Chen

Affiliations

Soon will be listed here.

Abstract

Background: Many serologic markers are routinely tested prior to joint arthroplasty, but only few are commonly used to guide surgeons in determining patients most at risk of periprosthetic joint infection (PJI). The objective of this study was to investigate the association between preoperative bilirubin level and PJI after primary hip and knee arthroplasty.

Methods: A retrospective analysis was performed on patients undergoing revision hip and knee arthroplasty at our hospital from January 2016 to December 2019. Laboratory biomarkers were collected before the primary arthroplasty, as well as general patient information. The association between the above serologic markers and postoperative PJI was analyzed.

Results: A total of 72 patients (30 hips/42 knees) were analyzed, including 39 patients with PJI and 33 patients without PJI. Except for total bilirubin (TB) and direct bilirubin (DB), there was no significant difference between the remaining laboratory biomarkers. The preoperative TB and DB in the PJI group were 10.84 ± 0.61 μmol/L and 3.07 ± 0.19 μmol/L, respectively, which were lower than those in the non-PJI group (14.68 ± 0.75 μmol/L and 4.70 ± 0.39 μmol/L, P < 0.001). The area under the curve (AUC) of preoperative TB to predict PJI was 0.755 (P < 0.001, cutoff = 11.55 μmol/L, sensitivity = 66.67%, specificity = 75.76%). Meanwhile, the AUC of preoperative DB was 0.760 (P < 0.001, cutoff = 4.00 μmol/L, sensitivity = 84.62%, specificity = 54.45%).

Conclusions: The serum levels of TB and DB before the primary arthroplasty were lower in PJI patients than in non-PJI patients, and the preoperative values lower than 11.55 μmol/L and 4.00 μmol/L could be considered as a risk factor for postoperative PJI.

Citing Articles

Correction to: The mildly decreased preoperative bilirubin level is a risk factor for periprosthetic joint infection after total hip and knee arthroplasty.

Fu J, Chen X, Ni M, Li X, Hao L, Zhang G Arthroplasty. 2022; 4(1):20.

PMID: 35410441 PMC: 8996421. DOI: 10.1186/s42836-022-00122-x.

References

Huotari K, Peltola M, Jamsen E . The incidence of late prosthetic joint infections: a registry-based study of 112,708 primary hip and knee replacements. Acta Orthop. 2015; 86(3):321-5. PMC: 4443453. DOI: 10.3109/17453674.2015.1035173. View

Greidanus N, Masri B, Garbuz D, Wilson S, McAlinden M, Xu M . Use of erythrocyte sedimentation rate and C-reactive protein level to diagnose infection before revision total knee arthroplasty. A prospective evaluation. J Bone Joint Surg Am. 2007; 89(7):1409-16. DOI: 10.2106/JBJS.D.02602. View

Del Toro M, Penas C, Conde-Albarracin A, Palomino J, Brun F, Sanchez S . Development and validation of baseline, perioperative and at-discharge predictive models for postsurgical prosthetic joint infection. Clin Microbiol Infect. 2018; 25(2):196-202. DOI: 10.1016/j.cmi.2018.04.023. View

Parvizi J, Tan T, Goswami K, Higuera C, Della Valle C, Chen A . The 2018 Definition of Periprosthetic Hip and Knee Infection: An Evidence-Based and Validated Criteria. J Arthroplasty. 2018; 33(5):1309-1314.e2. DOI: 10.1016/j.arth.2018.02.078. View

Parvizi J, Gehrke T . Definition of periprosthetic joint infection. J Arthroplasty. 2014; 29(7):1331. DOI: 10.1016/j.arth.2014.03.009. View

Bian L, Li R, Zhang Z, Jin Y, Kang H, Fang Z . Effects of total bilirubin on the prevalence of osteoporosis in postmenopausal women without potential liver disease. J Bone Miner Metab. 2013; 31(6):637-43. DOI: 10.1007/s00774-013-0452-y. View

Jamsen E, Varonen M, Huhtala H, Lehto M, Lumio J, Konttinen Y . Incidence of prosthetic joint infections after primary knee arthroplasty. J Arthroplasty. 2008; 25(1):87-92. DOI: 10.1016/j.arth.2008.10.013. View

Cook N, Paynter N, Eaton C, Manson J, Martin L, Robinson J . Comparison of the Framingham and Reynolds Risk scores for global cardiovascular risk prediction in the multiethnic Women's Health Initiative. Circulation. 2012; 125(14):1748-56, S1-11. PMC: 3324658. DOI: 10.1161/CIRCULATIONAHA.111.075929. View

Wallner M, Bulmer A, Molzer C, Mullner E, Marculescu R, Doberer D . Haem catabolism: a novel modulator of inflammation in Gilbert's syndrome. Eur J Clin Invest. 2013; 43(9):912-9. DOI: 10.1111/eci.12120. View

10.

Laky B, Alram I, Frank J, Pauzenberger L, Anderl W, Wagner K . Mildly decreased preoperative bilirubin levels are associated with infections after shoulder and knee arthroplasty. J Orthop Res. 2020; 38(9):2074-2082. DOI: 10.1002/jor.24620. View

11.

Juping D, Yuan Y, Shiyong C, Jun L, Xiuxiu Z, Haijian Y . Serum bilirubin and the risk of rheumatoid arthritis. J Clin Lab Anal. 2017; 31(6). PMC: 6817222. DOI: 10.1002/jcla.22118. View

12.

Tan T, Maltenfort M, Chen A, Shahi A, Higuera C, Siqueira M . Development and Evaluation of a Preoperative Risk Calculator for Periprosthetic Joint Infection Following Total Joint Arthroplasty. J Bone Joint Surg Am. 2018; 100(9):777-785. DOI: 10.2106/JBJS.16.01435. View

13.

Delanois R, Mistry J, Gwam C, Mohamed N, Choksi U, Mont M . Current Epidemiology of Revision Total Knee Arthroplasty in the United States. J Arthroplasty. 2017; 32(9):2663-2668. DOI: 10.1016/j.arth.2017.03.066. View

14.

Kim D, Lee Y, Kim M, Lee S, Jon S, Lee S . Bilirubin nanoparticles ameliorate allergic lung inflammation in a mouse model of asthma. Biomaterials. 2017; 140:37-44. DOI: 10.1016/j.biomaterials.2017.06.014. View

15.

Della Valle C, Sporer S, Jacobs J, Berger R, Rosenberg A, Paprosky W . Preoperative testing for sepsis before revision total knee arthroplasty. J Arthroplasty. 2007; 22(6 Suppl 2):90-3. DOI: 10.1016/j.arth.2007.04.013. View

16.

Horsfall L, Nazareth I, Petersen I . Cardiovascular events as a function of serum bilirubin levels in a large, statin-treated cohort. Circulation. 2012; 126(22):2556-64. DOI: 10.1161/CIRCULATIONAHA.112.114066. View

17.

Sigmund I, Holinka J, Lang S, Stenicka S, Staats K, Hobusch G . A comparative study of intraoperative frozen section and alpha defensin lateral flow test in the diagnosis of periprosthetic joint infection. Acta Orthop. 2019; 90(2):105-110. PMC: 6461083. DOI: 10.1080/17453674.2019.1567153. View

18.

Ghanem E, Parvizi J, Burnett R, Sharkey P, Keshavarzi N, Aggarwal A . Cell count and differential of aspirated fluid in the diagnosis of infection at the site of total knee arthroplasty. J Bone Joint Surg Am. 2008; 90(8):1637-43. DOI: 10.2106/JBJS.G.00470. View

19.

Grammatico-Guillon L, Rusch E, Astagneau P . Surveillance of prosthetic joint infections: international overview and new insights for hospital databases. J Hosp Infect. 2015; 89(2):90-8. DOI: 10.1016/j.jhin.2013.09.016. View

20.

Kapitulnik J . Bilirubin: an endogenous product of heme degradation with both cytotoxic and cytoprotective properties. Mol Pharmacol. 2004; 66(4):773-9. DOI: 10.1124/mol.104.002832. View